<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7296691</article-id>
    <article-id pub-id-type="publisher-id">3578</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-020-03578-3</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>RWRMTN: a tool for predicting disease-associated microRNAs based on a microRNA-target gene network</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4951-5916</contrib-id>
        <name>
          <surname>Le</surname>
          <given-names>Duc-Hau</given-names>
        </name>
        <address>
          <email>hauldhut@gmail.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tran</surname>
          <given-names>Trang T. H.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1"/>
      </contrib>
      <aff id="Aff1">Department of Computational Biomedicine, Vingroup Big Data Institute, No 7, Bang Lang 1 Street, Viet Hung Ward, Long Bien District, Hanoi, Vietnam </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>15</day>
      <month>6</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>15</day>
      <month>6</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>21</volume>
    <elocation-id>244</elocation-id>
    <history>
      <date date-type="received">
        <day>4</day>
        <month>10</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>1</day>
        <month>6</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The misregulation of microRNA (miRNA) has been shown to cause diseases. Recently, we have proposed a computational method based on a random walk framework on a miRNA-target gene network to predict disease-associated miRNAs. The prediction performance of our method is better than that of some existing state-of-the-art network- and machine learning-based methods since it exploits the mutual regulation between miRNAs and their target genes in the miRNA-target gene interaction networks.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">To facilitate the use of this method, we have developed a Cytoscape app, named RWRMTN, to predict disease-associated miRNAs. RWRMTN can work on any miRNA-target gene network. Highly ranked miRNAs are supported with evidence from the literature. They then can also be visualized based on the rankings and in relationships with the query disease and their target genes. In addition, automation functions are also integrated, which allow RWRMTN to be used in workflows from external environments. We demonstrate the ability of RWRMTN in predicting breast and lung cancer-associated miRNAs via workflows in Cytoscape and other environments.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">Considering a few computational methods have been developed as software tools for convenient uses, RWRMTN is among the first GUI-based tools for the prediction of disease-associated miRNAs which can be used in workflows in different environments.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Disease-associated miRNAs</kwd>
      <kwd>miRNA-target interaction</kwd>
      <kwd>Random walk with restart</kwd>
      <kwd>Automation</kwd>
      <kwd>Cytoscape app</kwd>
      <kwd>CyREST command APIs</kwd>
      <kwd>CyREST APIs</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007224</institution-id>
            <institution>National Foundation for Science and Technology Development</institution>
          </institution-wrap>
        </funding-source>
        <award-id>102.01-2017.14</award-id>
        <principal-award-recipient>
          <name>
            <surname>Le</surname>
            <given-names>Duc-Hau</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par6">Prediction of novel disease-associated miRNAs is an important task in biomedicine. A number of computational methods, including network-based and machine learning-based ones, have been introduced for predicting disease-associated miRNAs [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. However, few of them have been developed as prediction tools to facilitate their use [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. In general, disease similarity, miRNA similarity and known disease-miRNA associations are usually used as input data for both approaches [<xref ref-type="bibr" rid="CR6">6</xref>]. The similarity information was represented as networks (e.g., disease similarity network, miRNA similarity network) in network-based methods, then label propagation algorithms were often used to transfer disease-miRNA labels between miRNAs and diseases via the networks [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. Meanwhile, that information was often represented by matrices in some machine learning-based methods, then matrix factorization methods were used [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Network-based methods are mainly relied on homogeneous miRNA networks [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. In such networks, nodes represent miRNAs and edges represent the degree of functional similarity between miRNAs. Based on these homogeneous miRNA networks, associations between miRNAs and diseases are predicted based on the assumption that functionally related miRNAs associate with phenotypically similar diseases.</p>
    <p id="Par7">A common limitation of the homogeneous miRNA network-based methods is that the biological interactions between miRNAs and their target genes might be used ineffectively. This is because those interactions were only embedded as a degree of similarity among miRNAs. For instances, the similarity between two miRNAs was measured by a number of their shared target genes [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. These miRNA-target interactions, including both predicted and experimentally validated ones, are now largely available in a number of miRNA-target databases [<xref ref-type="bibr" rid="CR22">22</xref>] and become useful resources for analysis. This has inspired us to propose a novel network-based method for predicting disease-associated miRNA [<xref ref-type="bibr" rid="CR19">19</xref>] using miRNA-target gene interactions. More specifically, we exploited the mutual regulation between miRNAs and their target genes to construct mutual heterogeneous miRNA-target gene interaction networks (shortly called miRNA-target interaction networks) (i.e., nodes represent miRNAs and their target genes, and edges refer to the physical interactions between miRNAs and their target genes). We then proposed a novel method, namely RWRMTN, based on random walk with restart (RWR) algorithm on the miRNA-target interaction network to rank candidate miRNAs. Experiment results show that RWRMTN outperforms existing state-of-the-art methods including a network-based method RWRMDA [<xref ref-type="bibr" rid="CR10">10</xref>], which also uses the RWR algorithm but on homogeneous miRNA networks, and a machine learning-based method RLSMDA [<xref ref-type="bibr" rid="CR17">17</xref>]. RWRMTN was also proven to be stable, and it achieved relatively high performance for both experimentally validated and predicted miRNA-target gene networks [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
    <p id="Par8">Although many computational methods have been proposed for predicting disease-associated miRNAs, however, only a few of them have been developed as software tools which are convenient for biomedical applications. Indeed, we investigated 59 software tools for predicting disease-miRNA associations in OMICtools [<xref ref-type="bibr" rid="CR5">5</xref>], but most of them provided only source code and with command-line interfaces, which are not convenient for most of the biologists. Ten of them provide web-based interfaces, but only a few are accessible such as CHNmiRD [<xref ref-type="bibr" rid="CR23">23</xref>], OncomiR [<xref ref-type="bibr" rid="CR24">24</xref>] and miRConnect [<xref ref-type="bibr" rid="CR25">25</xref>] (Table <xref rid="Tab3" ref-type="table">3</xref> shows a comparison between RWRMTN with the ten web-based tools).</p>
    <p id="Par9">To facilitate the use of RWRMTN, we develop a tool running on the Cytoscape framework [<xref ref-type="bibr" rid="CR33">33</xref>] to predict disease-associated miRNAs. RWRMTN can rank all miRNA candidates in the miRNA-target gene network as well as candidates provided by users. In addition, it can provide evidence from literature about associations with the disease of interest for highly ranked miRNAs. These miRNAs then can also be visualized in relationships with their target genes as well as supporting evidence. Equipped by newly-introduced automation features of Cytoscape, the use of RWRMTN can be extended to workflows in other environments. Functions of RWRMTN were demonstrated in predicting breast and lung cancer-associated miRNAs via workflows in Cytoscape GUI platform and other environments.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <sec id="Sec3">
      <title>Main functions and workflow</title>
      <p id="Par10">RWRMTN is written as a Cytoscape app (Fig. <xref rid="Fig1" ref-type="fig">1</xref>(a)). The main task of RWRMTN is to predict novel disease-associated miRNAs. The primary result is ranking of candidate miRNAs based on our previously proposed method RWRMTN [<xref ref-type="bibr" rid="CR19">19</xref>] (see brief description in the next section). To make the result more reliable and intuitive, RWRMTN provides two more functions which are evidence collection and visualization. The evidence collection function gathers evidence from literature about the association of highly ranked miRNAs and the disease of interest. The visualization function builds a network of the selected miRNAs (e.g., highly ranked miRNAs) in relationships with their target genes and the disease of interest. To make RWRMTN reaches a wider range of users, we additionally implement automation features so that those functions of RWRMTN can be called using CyREST APIs and CyREST Command APIs from workflows written in other environments such as R and Python.
<fig id="Fig1"><label>Fig. 1</label><caption><p>An illustration of RWRMTN app and workflow for predicting disease-associated miRNAs. <bold>a</bold> Given a disease of interest, RWRMTN app is run on a miRNA-target network to rank candidate miRNAs, then highly ranked miRNAs are supported with evidence from literature and visualized by their rankings. These functions of RWRMTN app can be called in workflows from other environments (e.g., Bash script, Python, R, HTTP) using automation features (e.g., CyREST API). <bold>b</bold> Prediction of novel miRNAs associated with a disease of interest (e.g., breast cancer) can be done through four steps</p></caption><graphic xlink:href="12859_2020_3578_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par11">Prediction of novel disease-associated miRNAs is designed to complete through a four-step workflow (Fig. <xref rid="Fig1" ref-type="fig">1</xref>(b)). First, two datasets, including a miRNA-target interaction network and known disease-miRNA associations, must be specified. To facilitate the use of RWRMTN, we preinstalled some widely used datasets. However, to be flexible, the user can freely import others. Second, a disease of interest and candidate miRNAs are selected to rank. The candidates can be either all remaining miRNAs in the miRNA-target interaction network (i.e., excluding known miRNAs associated with the disease of interest) or freely inputted by the user. Third, highly ranked candidate miRNAs can be selected for an evidence search. More specifically, we searched for the co-occurrence of a candidate miRNA and the disease of interest from literature in PubMed via NCBI API [<xref ref-type="bibr" rid="CR34">34</xref>]. Thus, relevant evidence from newly published research will be retrieved each time of the evidence search. Evidenced miRNAs are provided with PubMed ID of the studies supporting an association between the miRNAs and the disease of interest. Finally, the selected miRNAs can be visualized based on their rankings and in relation with their target genes, the disease of interest and the supporting PubMed IDs.</p>
    </sec>
    <sec id="Sec4">
      <title>RWRMTN method</title>
      <p id="Par12">RWR is a variant of random walk algorithm, and it mimics a walker that moves from a current node in a network (i.e.<italic>,</italic> G(<italic>V</italic>, <italic>E</italic>) with a set of nodes <italic>V</italic> = {<italic>v</italic><sub><italic>1</italic></sub><italic>, v</italic><sub><italic>2</italic></sub><italic>, …, v</italic><sub><italic>N</italic></sub>} and a set of links <italic>E</italic> = {(<italic>v</italic><sub><italic>i</italic></sub><italic>, v</italic><sub><italic>j</italic></sub>)| <italic>v</italic><sub><italic>i</italic></sub><italic>, v</italic><sub><italic>j</italic></sub>∈<italic>V</italic>}, a set of seed nodes <italic>S</italic> ⊆ <italic>V</italic>) to a randomly selected adjacent node or goes back to source nodes (also called seed nodes) with a restart-probability (<italic>γ</italic>).
<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {p}_{t+1}=\left(1-\gamma \right){W}^{\prime }{p}_t+\gamma {p}_0 $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>γ</mml:mi></mml:mrow></mml:mfenced><mml:msup><mml:mi>W</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:msub><mml:mi>p</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mi>p</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><graphic xlink:href="12859_2020_3578_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where:
<list list-type="bullet"><list-item><p id="Par13"><italic>W′</italic> represents a transition probability matrix of the network</p></list-item><list-item><p id="Par14"><italic>p</italic><sub>t</sub> is a |<italic>V</italic>| × <italic>1</italic> probability vector of |<italic>V</italic>| nodes at a time step <italic>t</italic> of which the <italic>i</italic>th element represents the probability of the walker being at node <italic>v</italic><sub><italic>i</italic></sub>∈<italic>V</italic>.</p></list-item><list-item><p id="Par15"><italic>p</italic><sub><italic>0</italic></sub> is the |<italic>V</italic>| × <italic>1</italic> initial probability vector.</p></list-item></list></p>
      <p id="Par16">In RWRMDA method [<xref ref-type="bibr" rid="CR10">10</xref>], the RWR algorithm was used to rank miRNAs in homogeneous miRNA networks; therefore, the set of seed nodes (<italic>S</italic>) only contains known disease miRNA (<italic>S</italic><sub><italic>m</italic></sub>) (i.e., <italic>S</italic> = <italic>S</italic><sub><italic>m</italic></sub>).
<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left({p}_0\right)}_i=\left\{\begin{array}{c}\frac{1}{\left|{S}_m\right|}\ {ifv}_i\in {S}_m\\ {}\ 0\  otherwise\end{array}\right. $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mtable columnalign="center"><mml:mtr><mml:mtd><mml:mfrac><mml:mn>1</mml:mn><mml:mfenced close="|" open="|"><mml:msub><mml:mi>S</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mfenced></mml:mfrac><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="italic">ifv</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="0.25em"/><mml:mn>0</mml:mn><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">otherwise</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:math><graphic xlink:href="12859_2020_3578_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par17">In RWRMTN [<xref ref-type="bibr" rid="CR19">19</xref>], we assumed that the mutual regulation between a miRNA and their targets leads to a transfer of disease information between them. Therefore, we force the RWR algorithm to start from a set of seed nodes which consists of not only known disease miRNAs but also their target genes. In particular, we enlarge the set of seed node (<italic>S</italic>) by adding target genes (<italic>S</italic><sub><italic>g</italic></sub>) of the known disease miRNAs (i.e., <italic>S</italic>=<italic>S</italic><sub><italic>m</italic></sub>∪<italic>S</italic><sub><italic>g</italic></sub>), with <italic>α</italic>∈ (0, 1) is a weight parameter, which controls the disease information transferred between miRNAs and their target genes.
<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\left({p}_0\right)}_i=\left\{\begin{array}{c}\alpha \frac{1}{\left|{S}_m\right|}\ {ifv}_i\in {S}_m\\ {}\left(1-\alpha \right)\frac{1}{\left|{S}_g\right|}\ {ifv}_i\in {S}_g\\ {}0\  otherwise\end{array}\right. $$\end{document}</tex-math><mml:math id="M6" display="block"><mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mfenced><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mtable columnalign="center"><mml:mtr><mml:mtd><mml:mi>α</mml:mi><mml:mfrac><mml:mn>1</mml:mn><mml:mfenced close="|" open="|"><mml:msub><mml:mi>S</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mfenced></mml:mfrac><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="italic">ifv</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>α</mml:mi></mml:mrow></mml:mfenced><mml:mfrac><mml:mn>1</mml:mn><mml:mfenced close="|" open="|"><mml:msub><mml:mi>S</mml:mi><mml:mi>g</mml:mi></mml:msub></mml:mfenced></mml:mfrac><mml:mspace width="0.25em"/><mml:msub><mml:mi mathvariant="italic">ifv</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>g</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">otherwise</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:math><graphic xlink:href="12859_2020_3578_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par18">For both methods, all miRNAs in the network are eventually ranked according to the steady-state probability vector <italic>p</italic><sub><italic>∞</italic></sub>, which is obtained by repeating the iterations until convergence is reached (in this study, ||<italic>p</italic><sub>t + 1</sub>-<italic>p</italic><sub>t</sub>|| &lt; 10<sup>− 6</sup>).</p>
      <p id="Par19">In the previous study, we have investigated the effects of the restart-probability (<italic>γ</italic>) and the weight parameter (<italic>α</italic>) on the prediction performance of RWRMTN on two miRNA-target gene networks. More specifically, we varied the weight parameter (α) in the range {0.1, 0.3, 0.5, 0.7, 0.9} and the restart probability <italic>γ</italic> in the range [0.1, 0.9] in steps of 0.1. Experimental results showed that the performance of RWRMTN slightly increased according to the change of the weight parameter in both the networks. This indicates that disease information contained in known disease miRNAs is still more important than that in their target genes when ranking candidate disease-associated miRNAs. In addition, RWRMTN is either slightly better or stable when the restart probability <italic>γ</italic> increased in the two networks. The slight increase in the prediction performance in a network suggested that disease miRNAs in that network are less modularized than the other.</p>
    </sec>
    <sec id="Sec5">
      <title>Preinstalled data</title>
      <p id="Par20">To facilitate the use of the app, we preinstalled some datasets. First, two miRNA-target gene networks collected from an experimentally validated dataset, miRWalk [<xref ref-type="bibr" rid="CR35">35</xref>] and a predicted dataset, TargetScan [<xref ref-type="bibr" rid="CR36">36</xref>] were preinstalled (Table <xref rid="Tab1" ref-type="table">1</xref>). However, the user can import any other miRNA-target gene network to use. Second, two known disease-miRNA association datasets were also pre-collected, i.e., miR2Disease [<xref ref-type="bibr" rid="CR37">37</xref>] and HMDD [<xref ref-type="bibr" rid="CR38">38</xref>] (Table <xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Preinstalled miRNA-target gene interaction datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Datasets</th><th>Number of miRNAs</th><th>Number of target genes</th><th>Number of known interactions</th></tr></thead><tbody><tr><td>miRWalk</td><td>740</td><td>11,976</td><td>38,569</td></tr><tr><td>TargetScan</td><td>1537</td><td>15,031</td><td>520,256</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Preinstalled known disease-miRNA association datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Datasets</th><th>Number of miRNAs</th><th>Number of diseases</th><th>Number of known associations</th></tr></thead><tbody><tr><td>miR2Disease</td><td>118</td><td>53</td><td>270</td></tr><tr><td>HMDD</td><td>574</td><td>243</td><td>5618</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <p id="Par21">The overall prediction performance of RWRMTN on a set of diseases was reported in our previous study [<xref ref-type="bibr" rid="CR19">19</xref>]. In this section, the effectiveness of RWRMTN was demonstrated for breast cancer in two case studies via different scenarios. Given the breast cancer with their known associated miRNAs, firstly, all other miRNAs in the miRNA-target networks were used as candidates. The overall performance of RWRMTN in terms of AUC (Area under the ROC curve) for breast cancer was assessed using a leave-one-out cross-validation (LOOCV) scheme (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Then, the candidates were ranked and supported with evidence. More specifically, we performed this task with candidate miRNAs from the miRNA-target gene network constructed from TargetScan [<xref ref-type="bibr" rid="CR36">36</xref>] based on 31 known breast cancer-associated miRNAs reported in miR2Disease [<xref ref-type="bibr" rid="CR37">37</xref>] using Cytoscape menu and Command APIs via the four-step workflow (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). As a result, four of top 10 miRNA candidates were supported with evidence from literature about their associations with breast cancer. Secondly, only miRNAs that were differentially expressed between case and control samples were used as the candidates for ranking. More specifically, we ranked 799 miRNAs that were differentially expressed between the 64 wild-type samples and 36 <italic>TP53</italic> mutant breast cancer samples collected from [<xref ref-type="bibr" rid="CR39">39</xref>] via CyREST API called in R environment using the miRNA-target gene network constructed from miRWalk [<xref ref-type="bibr" rid="CR35">35</xref>] and the known disease-miRNA association dataset HMDD [<xref ref-type="bibr" rid="CR38">38</xref>]. The scripts for calling the CyREST API in other environments such as Python and Bash were also introduced. Furthermore, another case study on lung cancer was demonstrated (See more detail in Additional file <xref rid="MOESM1" ref-type="media">1</xref>).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Prediction performance of breast cancer by RWRMTN on the two miRNA-target gene datasets (miRWalk and TargetScan). <bold>a</bold> The AUC values when the restart probability was varied in a range [0.1, 0.9]. <bold>b</bold> The ROC curve and the AUC values when the restart probability was set to 0.5 for the case study. For all experiments, the weight parameter was set to 0.5</p></caption><graphic xlink:href="12859_2020_3578_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>A four-step workflow of RWRMTN for predicting breast cancer-associated miRNAs. <italic>Step1: Load datasets</italic>: a miRNA-target interaction dataset and a known disease-miRNA association dataset must be selected. <italic>Step 2: Rank candidate miRNAs</italic>: a disease of interest (e.g., breast cancer) is chosen, then a set of candidate miRNAs is specified and ranked. <italic>Step 3: Search Evidences</italic>: Top-ranked candidate miRNAs are selected and provided with evidence from literature about their associations with the disease of interest. <italic>Step 4: Rank-based visualization</italic>: the selected candidate miRNAs are visualized based on their rankings and their relationships with the disease of interest, known breast cancer-associated miRNAs and supporting PubMed IDs. These steps can be performed by either the Cytoscape menu or CyREST Command APIs called from other environments (e.g., R)</p></caption><graphic xlink:href="12859_2020_3578_Fig3_HTML" id="MO3"/></fig></p>
    <sec id="Sec7">
      <title>Comparison between RWRMTN with other tools</title>
      <p id="Par22">We investigated 59 software tools (as of 16th March 2020) for predicting disease-miRNA associations in OMICtools [<xref ref-type="bibr" rid="CR5">5</xref>] which has accumulated tens of thousands of tools for omics data. However, most of them provide only source code and with command-line interfaces, which are not convenient for most of the biologists. Indeed, 14 out of the 59 tools are web-based including: mirfluence [<xref ref-type="bibr" rid="CR26">26</xref>], Ifmda [<xref ref-type="bibr" rid="CR27">27</xref>], CHNmiRD [<xref ref-type="bibr" rid="CR23">23</xref>], miRiaD [<xref ref-type="bibr" rid="CR28">28</xref>], OncomiR [<xref ref-type="bibr" rid="CR24">24</xref>], miRPD [<xref ref-type="bibr" rid="CR40">40</xref>], MIDP [<xref ref-type="bibr" rid="CR30">30</xref>], DISMIRA [<xref ref-type="bibr" rid="CR31">31</xref>], MDHGI [<xref ref-type="bibr" rid="CR32">32</xref>], CMP [<xref ref-type="bibr" rid="CR29">29</xref>], miRConnect [<xref ref-type="bibr" rid="CR25">25</xref>], DMPred [<xref ref-type="bibr" rid="CR41">41</xref>], MMiRNA-Tar [<xref ref-type="bibr" rid="CR42">42</xref>] and miRNACon [<xref ref-type="bibr" rid="CR43">43</xref>]. However, the web page of DMPred [<xref ref-type="bibr" rid="CR41">41</xref>] could not be found, and miRPD [<xref ref-type="bibr" rid="CR40">40</xref>] was actually designed for identifying microRNAs from deep sequencing data. In addition, MMiRNA-Tar [<xref ref-type="bibr" rid="CR42">42</xref>] and miRNACon [<xref ref-type="bibr" rid="CR43">43</xref>] were not designed specifically for predicting disease-associated miRNAs. Thus, the four tools were eliminated from the comparison. Thus, we finally have compared the rest (ten tools) with RWRMTN (Table <xref rid="Tab3" ref-type="table">3</xref>).
<table-wrap id="Tab3"><label>Table 3</label><caption><p>A comparison between RWRMTN and other tools for predicting disease-associated miRNAs</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Tools</th><th colspan="4">Function</th><th colspan="2">Others</th><th rowspan="2">Website</th><th rowspan="2">Accessible</th></tr><tr><th><italic>Ranking</italic></th><th><italic>Evidence search</italic></th><th><italic>Visualize</italic></th><th><italic>Automation</italic></th><th><italic>Multiple diseases</italic></th><th><italic>User-defined datasets</italic></th></tr></thead><tbody><tr><td><bold>RWRMTN</bold></td><td>✓</td><td>✓</td><td>✓</td><td>✓</td><td>✓</td><td>✓</td><td><ext-link ext-link-type="uri" xlink:href="http://apps.cytoscape.org/apps/rwrmtn"><italic>http://apps.cytoscape.org/apps/rwrmtn</italic></ext-link></td><td>✓</td></tr><tr><td><bold>miRfluence</bold> [<xref ref-type="bibr" rid="CR26">26</xref>]</td><td>✓</td><td/><td>✓</td><td/><td>✓</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://bnet.egr.vcu.edu/mirfluence"><italic>http://bnet.egr.vcu.edu/mirfluence</italic></ext-link></td><td/></tr><tr><td><bold>Ifmda</bold> [<xref ref-type="bibr" rid="CR27">27</xref>]</td><td>✓</td><td/><td/><td/><td>✓</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://lab.malab.cn/soft/ifmda"><italic>http://lab.malab.cn/soft/ifmda</italic></ext-link></td><td/></tr><tr><td><bold>CHNmiRD</bold> [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td>✓</td><td/><td/><td/><td>✓</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://www.bio-bigdata.com/CHNmiRD"><italic>http://www.bio-bigdata.com/CHNmiRD</italic></ext-link></td><td>✓</td></tr><tr><td><bold>miRiaD</bold> [<xref ref-type="bibr" rid="CR28">28</xref>]</td><td>✓</td><td>✓</td><td/><td/><td>✓</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://biotm.cis.udel.edu/miRiaD"><italic>http://biotm.cis.udel.edu/miRiaD</italic></ext-link></td><td/></tr><tr><td><bold>OncomiR</bold> [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td>✓</td><td>✓</td><td/><td/><td>Cancer</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://www.oncomir.org"><italic>http://www.oncomir.org</italic></ext-link></td><td>✓</td></tr><tr><td>CMP [<xref ref-type="bibr" rid="CR29">29</xref>]</td><td>✓</td><td>✓</td><td/><td/><td>Cancer</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://bioinfo.hrbmu.edu.cn/CMP"><italic>http://bioinfo.hrbmu.edu.cn/CMP</italic></ext-link></td><td/></tr><tr><td><bold>MIDP</bold> [<xref ref-type="bibr" rid="CR30">30</xref>]</td><td>✓</td><td/><td/><td/><td>✓</td><td/><td><italic>http://bioinfolab.stx.hk/midp/</italic></td><td/></tr><tr><td><bold>DISMIRA</bold> [<xref ref-type="bibr" rid="CR31">31</xref>]</td><td>✓</td><td/><td>✓</td><td/><td>✓</td><td/><td><italic>http://bnet.egr.vcu.edu:8080/dismira</italic></td><td/></tr><tr><td><bold>MDHGI</bold> [<xref ref-type="bibr" rid="CR32">32</xref>]</td><td>✓</td><td>✓</td><td/><td/><td>✓</td><td/><td><italic>http://chengroup.cumt.edu.cn/tool/mdhgi/</italic></td><td/></tr><tr><td><bold>miRConnect</bold> [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td>✓</td><td/><td/><td/><td>Cancer</td><td/><td><ext-link ext-link-type="uri" xlink:href="http://mirconnect.org:8002/miRConnect/"><italic>http://mirconnect.org:8002/miRConnect/</italic></ext-link></td><td>✓</td></tr></tbody></table></table-wrap></p>
      <p id="Par23">In the aspect of function comparison to RWRMTN, as tools for predicting disease-associated miRNAs, all of them provided ranking for candidate miRNAs, however only four of them provided evidence for potential disease-miRNA associations. RWRMTN, on the other hand, integrated NCBI API [<xref ref-type="bibr" rid="CR34">34</xref>] to the evidence search function, thus relevant evidence from recently published research will be retrieved each time users perform the task. Besides displaying the results in tabular form, only two tools visualized the association between miRNAs and diseases. In contrast, highly ranked miRNAs, known miRNAs, target genes, the disease of interest as well as supporting PubMed IDs and their associations could be intuitively viewed in a network in RWRMTN. Lastly, none of them provides automation function of reproducibility to different environments. Equipped with CyREST API of Cytoscape platform, RWRMTN functions can be invoked from any workflows running in other environments. In other aspects, like most of the tools, RWRMTN was also designed for multiple diseases. However, it is more flexible in providing the input data, since users can opt between preinstalled datasets or their own. None of the web-based tools provided this function. Finally, only three out of the ten web-based tools can be accessed via links provided in their publications. In contrast, RWRMTN is easy to be managed and maintained since the available update of RWRMTN will be notified by Cytoscape.</p>
    </sec>
    <sec id="Sec8">
      <title>Prediction of breast cancer-associated miRNAs using Cytoscape menu and CyREST command API</title>
      <p id="Par24">In this section, we demonstrate the use of RWRMTN in predicting novel breast cancer-associated miRNAs by the four-step workflow. The workflow can be accomplished using either Cytoscape menu or CyREST Command API (Fig. <xref rid="Fig4" ref-type="fig">4</xref>) (See more detail in Additional file <xref rid="MOESM1" ref-type="media">1</xref>).
<fig id="Fig4"><label>Fig. 4</label><caption><p>Perform the four-step workflow of RWRMTN. <bold>a</bold> via Cytoscape menu (Apps ➔ RWRMTN). <bold>b</bold> via CyREST Command APIs (Help ➔ Automation ➔ CyREST Command API ➔ RWRMTN)</p></caption><graphic xlink:href="12859_2020_3578_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par25">For the first step, a miRNA-target interaction dataset TargetScan [<xref ref-type="bibr" rid="CR36">36</xref>] and a known disease-miRNA association dataset miR2Disease [<xref ref-type="bibr" rid="CR37">37</xref>] were used. Note that, besides the two preinstalled datasets, miRNA-target interaction network can be freely imported by the user.</p>
      <p id="Par26">For the second step, a set of candidate miRNAs for breast cancer (OMIM ID: 114480) is ranked. To this end, we first selected the disease, then all miRNAs in the selected miRNA-target interaction network were selected as candidates for ranking. Note that, users can manually input candidate miRNAs or import them from a file. After that, the candidate miRNAs were ranked by the RWRMTN method [<xref ref-type="bibr" rid="CR19">19</xref>] with default parameter settings (See more detail in Additional file <xref rid="MOESM1" ref-type="media">1</xref>).</p>
      <p id="Par27">For the third step, we selected the top ten ranked candidate miRNAs, then find the evidence of their associations with breast cancer from literature (PubMed). As a result, four of them were supported with evidence from literature about their associations with breast cancer (Fig. <xref rid="Fig5" ref-type="fig">5</xref>).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Ranked candidate miRNAs. Top-ranked candidate miRNAs were selected and provided with evidence from the literature (highlighted part)</p></caption><graphic xlink:href="12859_2020_3578_Fig5_HTML" id="MO5"/></fig></p>
      <p id="Par28">For example, <italic>hsa-miR-506</italic> was supported by five studies (PubMed IDs: 23717581, 25707493, 26059632, 26398880 and 27542202). The study (PubMed ID: 23717581) [<xref ref-type="bibr" rid="CR44">44</xref>] showed that has-miR-506 regulates epithelial-mesenchymal transition in breast cancer cell lines. Meanwhile, the study (PubMed ID: 26059632) [<xref ref-type="bibr" rid="CR45">45</xref>] proved notable inhibition of <italic>hsa-miR-506</italic> over-expression to proliferation and metastasis of breast cancer cells. In addition, study (PubMed ID: 26398880) [<xref ref-type="bibr" rid="CR46">46</xref>] indicated that the mechanism underlying miRNA-506 is a contributing factor in breast carcinogenesis (<italic>has-miR-506</italic> was proven to be a tumor suppressor). In addition, <italic>hsa-miR-520d-5p</italic> supported by a study (PubMed ID: 28721278) [<xref ref-type="bibr" rid="CR47">47</xref>]. More specifically, it was reported that this miRNA upregulates the activation of BRCA1 (breast cancer 1, early onset) in the DNA repair process – 35 days after transfection. Moreover, <italic>hsa-miR-4319</italic> was showed in study PubMed ID: 30021199 as a suppressor of the malignancy of triple-negative breast cancer by regulating self-renewal and tumorigenesis of stem cells. Finally, <italic>hsa-miR-106b</italic> was proven by the experiment carried on patient samples and cell lines in the study (PubMed ID: 26621835) [<xref ref-type="bibr" rid="CR48">48</xref>].</p>
      <p id="Par29">For the final step, the top selected candidate miRNAs can be visualized in a network based on the rankings. In addition, target genes, the disease of interest and detail information of PubMed IDs collected from Step 3 such as <italic>paper title, author list, journal name</italic> can be displayed aside in this network (Fig. <xref rid="Fig6" ref-type="fig">6</xref>).
<fig id="Fig6"><label>Fig. 6</label><caption><p>Visualization of top-ranked candidate miRNAs and breast cancer. <bold>a</bold> With supporting PubMed IDs and (<bold>b</bold>) detail information of the selected PubMed ID. <bold>c</bold> With known breast cancer-associated miRNAs. PubMed IDs, disease, candidate and known miRNAs are represented in parallelogram, octagon, ellipse and triangle shapes, respectively. The darker red a miRNA is the higher ranking it has. Known and candidate associations with the disease are represented by solid and dashed lines, respectively</p></caption><graphic xlink:href="12859_2020_3578_Fig6_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Prediction of breast cancer-associated miRNAs by calling CyREST API</title>
      <p id="Par30">In this section, we first introduce some developed CyREST APIs, which provides some helpful functions. Second, we demonstrate their use in a workflow in R environment.</p>
      <p id="Par31">A total of four CyREST APIs were developed in RWRMTN (Fig. <xref rid="Fig7" ref-type="fig">7</xref>): First, GET /RWRMTN/v1/diseaseList returns a list of all diseases (OMIM ID and disease name) available in the selected known disease-miRNA association database (e.g., HMDD [<xref ref-type="bibr" rid="CR38">38</xref>]). Based on this list, users can select a disease of interest. Second, GET /RWRMTN/v1/diseaseList/{diseaseName} provides a list of diseases whose names match the query {diseaseName} parameter (e.g., breast). This API helps user narrow down the list of diseases to the disease of interest (e.g., OMIM ID 114480 for breast cancer). Third, POST /RWRMTN/v1/rank lets RWRMTN rank candidate miRNAs. Finally, GET:/RWRMTN/v1/getRank/{limit} returns top-ranked miRNAs by setting {limit} parameter.
<fig id="Fig7"><label>Fig. 7</label><caption><p>CyREST APIs of RWRMTN. The four APIs are used to query from datasets in the app (GET) and to let the app rank candidate miRNAs (POST)</p></caption><graphic xlink:href="12859_2020_3578_Fig7_HTML" id="MO7"/></fig></p>
      <p id="Par32">In this case study, we used a dataset GSE19783 from a study [<xref ref-type="bibr" rid="CR39">39</xref>] published in NCBI GEO [<xref ref-type="bibr" rid="CR49">49</xref>], which was created using Agilent-019118 Human miRNA Microarray 2.0 G4470B platform (GPL8227) and Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (GPL6480) (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19783">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE19783</ext-link>). The study characterizes breast cancer subtypes from joint analysis of high throughput miRNA (using GPL8227) and mRNA (using GPL6480) data.</p>
      <p id="Par33">In this case study, we identified 799 candidate miRNAs which were differentially expressed between the 64 wild-type samples (WT) and 36 <italic>TP53</italic> mutant samples. Then, we ranked the candidate miRNAs by RWRMTN via a CyREST API using a miRNA-target interaction dataset miRWalk [<xref ref-type="bibr" rid="CR35">35</xref>] and a known disease-miRNA association dataset HMDD [<xref ref-type="bibr" rid="CR38">38</xref>] via workflow in R environment using CyREST API POST /RWRMTN/v1/rank (See more detail in Additional file <xref rid="MOESM1" ref-type="media">1</xref>).</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Conclusions</title>
    <p id="Par34">In this study, we introduce a tool as a Cytoscape app, RWRMTN, for predicting novel disease-associated miRNAs. The tool was developed based on our previously proposed method with the same name, which was proven to be better than other state-of-the-art methods on overall prediction performance and to have the ability in predicting novel miRNAs associated with 23 diseases [<xref ref-type="bibr" rid="CR19">19</xref>]. Because the core method is a network-based, thus RWRMTN can exploit network integration and visualization functions of Cytoscape. In particular, the tool relies on miRNA-target gene networks to rank candidate miRNAs with supporting functions such as evidence collection and visualization for highly ranked candidate miRNAs. In addition, by implementing automation functions, it can be used in workflows in other environments. We further demonstrate the use of RWRMTN by showing its ability in predicting novel breast and lung cancer-associated miRNAs.</p>
    <sec id="Sec11">
      <title>Availability and requirements</title>
      <p id="Par35"><bold>Project name:</bold> RWRMTN</p>
      <p id="Par36">
        <bold>Project home page:</bold>
        <ext-link ext-link-type="uri" xlink:href="https://github.com/hauldhut/RWRMTN">https://github.com/hauldhut/RWRMTN</ext-link>
      </p>
      <p id="Par37"><bold>Operating system(s):</bold> Mac OS, Linux, Windows</p>
      <p id="Par38"><bold>Programming language:</bold> Java</p>
      <p id="Par39"><bold>Other requirements:</bold> JDK 1.8 or higher, Cytoscape 3.x or higher</p>
      <p id="Par40"><bold>License:</bold> Apache License</p>
      <p id="Par41"><bold>Any restrictions to use by non-academics:</bold> licence needed</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec12">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12859_2020_3578_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1.</bold> User manual &amp; Case studies.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>GUI</term>
        <def>
          <p id="Par4">Graphical User Interface</p>
        </def>
      </def-item>
      <def-item>
        <term>RWR</term>
        <def>
          <p id="Par5">Random Walk with Restart</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12859-020-03578-3.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>DHL conceived of the study, developed the core algorithm, TTHT developed the Cytoscape app. DHL wrote the manuscript, TTHT wrote the User manual. DHL and TTHT both wrote the case studies and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 102.01–2017.14.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>RWRMTN is distributed as a Cytoscape app, and can be downloaded freely at Cytoscape App <ext-link ext-link-type="uri" xlink:href="https://apps.cytoscape.org/apps/rwrmtn">https://apps.cytoscape.org/apps/rwrmtn</ext-link> for non-commercial use.</p>
  </notes>
  <notes id="FPar1">
    <title>Ethics approval and consent to participate</title>
    <p id="Par42">Not applicable.</p>
  </notes>
  <notes id="FPar2">
    <title>Consent for publication</title>
    <p id="Par43">Not applicable.</p>
  </notes>
  <notes id="FPar3" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par44">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks</article-title>
        <source>Brief Bioinform</source>
        <year>2016</year>
        <volume>17</volume>
        <issue>2</issue>
        <fpage>193</fpage>
        <lpage>203</lpage>
        <?supplied-pmid 26059461?>
        <pub-id pub-id-type="pmid">26059461</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Z-H</given-names>
          </name>
        </person-group>
        <article-title>MicroRNAs and complex diseases: from experimental results to computational models</article-title>
        <source>Brief Bioinform</source>
        <year>2017</year>
        <volume>20</volume>
        <fpage>bbx130</fpage>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Benchmark of computational methods for predicting microRNA-disease associations</article-title>
        <source>Genome Biol</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>202</fpage>
        <?supplied-pmid 31594544?>
        <pub-id pub-id-type="pmid">31594544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Heikkinen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <source>Trends in the development of miRNA bioinformatics tools</source>
        <year>2018</year>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <mixed-citation publication-type="other">Henry VJ, Bandrowski AE, Pepin A-S, Gonzalez BJ, Desfeux A. OMICtools: an informative directory for multi-omic data analysis. Database. 2014;2014. <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/database/article/doi/10.1093/database/bau069/2634692">https://academic.oup.com/database/article/doi/10.1093/database/bau069/2634692</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <mixed-citation publication-type="other">Le D-H. A general computational framework for prediction of disease-associated non-coding RNAs. VNU J Sci Comput Sci Commun Eng. 2019;35(2). <ext-link ext-link-type="uri" xlink:href="http://www.jcsce.vnu.edu.vn/index.php/jcsce/article/view/224">http://www.jcsce.vnu.edu.vn/index.php/jcsce/article/view/224</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>D-H</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Z-H</given-names>
          </name>
        </person-group>
        <article-title>A heterogeneous label propagation approach to explore the potential associations between miRNA and disease</article-title>
        <source>J Transl Med</source>
        <year>2018</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>348</fpage>
        <?supplied-pmid 30537965?>
        <pub-id pub-id-type="pmid">30537965</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Predicting microRNA-disease associations using label propagation based on linear neighborhood similarity</article-title>
        <source>J Biomed Inform</source>
        <year>2018</year>
        <volume>82</volume>
        <fpage>169</fpage>
        <lpage>177</lpage>
        <?supplied-pmid 29763707?>
        <pub-id pub-id-type="pmid">29763707</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>S-P</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>G-H</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>P-J</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>J-W</given-names>
          </name>
        </person-group>
        <article-title>MCLPMDA: a novel method for miRNA-disease association prediction based on matrix completion and label propagation</article-title>
        <source>J Cell Mol Med</source>
        <year>2019</year>
        <volume>23</volume>
        <issue>2</issue>
        <fpage>1427</fpage>
        <lpage>1438</lpage>
        <?supplied-pmid 30499204?>
        <pub-id pub-id-type="pmid">30499204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>M-X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>RWRMDA: predicting novel human microRNA-disease associations</article-title>
        <source>Mol BioSyst</source>
        <year>2012</year>
        <volume>8</volume>
        <issue>10</issue>
        <fpage>2792</fpage>
        <lpage>2798</lpage>
        <?supplied-pmid 22875290?>
        <pub-id pub-id-type="pmid">22875290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le</surname>
            <given-names>D-H</given-names>
          </name>
        </person-group>
        <article-title>Network-based ranking methods for prediction of novel disease associated microRNAs</article-title>
        <source>Comput Biol Chem</source>
        <year>2015</year>
        <volume>58</volume>
        <fpage>139</fpage>
        <lpage>148</lpage>
        <?supplied-pmid 26231308?>
        <pub-id pub-id-type="pmid">26231308</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <issue>8</issue>
        <fpage>e70204</fpage>
        <?supplied-pmid 23950912?>
        <pub-id pub-id-type="pmid">23950912</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Similarity-based methods for potential human microRNA-disease association prediction</article-title>
        <source>BMC Med Genet</source>
        <year>2013</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>12</fpage>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y-T</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Q-W</given-names>
          </name>
          <name>
            <surname>Ni</surname>
            <given-names>J-C</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
        </person-group>
        <article-title>Graph regularized L2,1-nonnegative matrix factorization for miRNA-disease association prediction</article-title>
        <source>BMC Bioinformatics</source>
        <year>2020</year>
        <volume>21</volume>
        <issue>1</issue>
        <fpage>61</fpage>
        <?supplied-pmid 32070280?>
        <pub-id pub-id-type="pmid">32070280</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S-X</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C-C</given-names>
          </name>
        </person-group>
        <article-title>Potential miRNA-disease association prediction based on kernelized Bayesian matrix factorization</article-title>
        <source>Genomics</source>
        <year>2020</year>
        <volume>112</volume>
        <issue>1</issue>
        <fpage>809</fpage>
        <lpage>819</lpage>
        <?supplied-pmid 31136792?>
        <pub-id pub-id-type="pmid">31136792</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
        </person-group>
        <article-title>NPCMF: nearest profile-based collaborative matrix factorization method for predicting miRNA-disease associations</article-title>
        <source>BMC Bioinformatics</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>353</fpage>
        <?supplied-pmid 31234797?>
        <pub-id pub-id-type="pmid">31234797</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>Semi-supervised learning for potential human microRNA-disease associations inference</article-title>
        <source>Sci Rep</source>
        <year>2014</year>
        <volume>4</volume>
        <fpage>5501</fpage>
        <?supplied-pmid 24975600?>
        <pub-id pub-id-type="pmid">24975600</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Juan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Prioritization of disease microRNAs through a human phenome-microRNAome network</article-title>
        <source>BMC Syst Biol</source>
        <year>2010</year>
        <volume>4</volume>
        <issue>Suppl 1</issue>
        <fpage>S2</fpage>
        <?supplied-pmid 20522252?>
        <pub-id pub-id-type="pmid">20522252</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le</surname>
            <given-names>D-H</given-names>
          </name>
          <name>
            <surname>Verbeke</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Son</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>D-T</given-names>
          </name>
          <name>
            <surname>Pham</surname>
            <given-names>V-H</given-names>
          </name>
        </person-group>
        <article-title>Random walks on mutual microRNA-target gene interaction network improve the prediction of disease-associated microRNAs</article-title>
        <source>BMC Bioinformatics</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>479</fpage>
        <?supplied-pmid 29137601?>
        <pub-id pub-id-type="pmid">29137601</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Le</surname>
            <given-names>D-H</given-names>
          </name>
        </person-group>
        <article-title>Disease phenotype similarity improves the prediction of novel disease-associated microRNAs</article-title>
        <source>Information and Computer Science (NICS), 2015 2nd National Foundation for Science and Technology Development Conference on: 16–18 Sept. 2015</source>
        <year>2015</year>
        <fpage>76</fpage>
        <lpage>81</lpage>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Le</surname>
            <given-names>D-H</given-names>
          </name>
          <name>
            <surname>Marchal</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Integration of miRNA-miRNA networks improves the prediction of novel disease associated miRNAs</article-title>
        <source>The First NAFOSTED Conference on Information and Computer Science<italic>;</italic> Hanoi</source>
        <year>2014</year>
        <fpage>438</fpage>
        <lpage>448</lpage>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tan Gana</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>Victoriano</surname>
            <given-names>AFB</given-names>
          </name>
          <name>
            <surname>Okamoto</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Evaluation of online miRNA resources for biomedical applications</article-title>
        <source>Genes Cells</source>
        <year>2012</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>11</fpage>
        <lpage>27</lpage>
        <?supplied-pmid 22077698?>
        <pub-id pub-id-type="pmid">22077698</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Integration of multiple genomic and phenotype data to infer novel miRNA-disease associations</article-title>
        <source>PLoS One</source>
        <year>2016</year>
        <volume>11</volume>
        <issue>2</issue>
        <fpage>e0148521</fpage>
        <?supplied-pmid 26849207?>
        <pub-id pub-id-type="pmid">26849207</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>NW</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>OncomiR: an online resource for exploring pan-cancer microRNA dysregulation</article-title>
        <source>Bioinformatics</source>
        <year>2017</year>
        <volume>34</volume>
        <issue>4</issue>
        <fpage>713</fpage>
        <lpage>715</lpage>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hua</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Murmann</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Larsen</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kjems</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lund</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Peter</surname>
            <given-names>ME</given-names>
          </name>
        </person-group>
        <article-title>miRConnect: identifying effector genes of miRNAs and miRNA families in cancer cells</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>10</issue>
        <fpage>e26521</fpage>
        <?supplied-pmid 22046300?>
        <pub-id pub-id-type="pmid">22046300</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nalluri</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Rana</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Barh</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Azevedo</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Dinh</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Vladimirov</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Ghosh</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Determining causal miRNAs and their signaling cascade in diseases using an influence diffusion model</article-title>
        <source>Sci Rep</source>
        <year>2017</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>8133</fpage>
        <?supplied-pmid 28811509?>
        <pub-id pub-id-type="pmid">28811509</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Inferring MicroRNA-disease associations by random walk on a heterogeneous network with multiple data sources</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2017</year>
        <volume>14</volume>
        <issue>4</issue>
        <fpage>905</fpage>
        <lpage>915</lpage>
        <?supplied-pmid 27076459?>
        <pub-id pub-id-type="pmid">27076459</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ross</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Tudor</surname>
            <given-names>CO</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Schmidt</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Vijay-Shanker</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>miRiaD: a text mining tool for detecting associations of microRNAs with diseases</article-title>
        <source>J Biomed Semantics</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>9</fpage>
        <?supplied-pmid 27216254?>
        <pub-id pub-id-type="pmid">27216254</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lv</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ning</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prioritizing human cancer microRNAs based on genes’ functional consistency between microRNA and cancer</article-title>
        <source>Nucleic Acids Res</source>
        <year>2011</year>
        <volume>39</volume>
        <issue>22</issue>
        <fpage>e153</fpage>
        <?supplied-pmid 21976726?>
        <pub-id pub-id-type="pmid">21976726</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Prediction of potential disease-associated microRNAs based on random walk</article-title>
        <source>Bioinformatics</source>
        <year>2015</year>
        <volume>31</volume>
        <issue>11</issue>
        <fpage>1805</fpage>
        <lpage>1815</lpage>
        <?supplied-pmid 25618864?>
        <pub-id pub-id-type="pmid">25618864</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nalluri</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Kamapantula</surname>
            <given-names>BK</given-names>
          </name>
          <name>
            <surname>Barh</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jain</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Bhattacharya</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>de Almeida</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Juca Ramos</surname>
            <given-names>RT</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Azevedo</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Ghosh</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>DISMIRA: prioritization of disease candidates in miRNA-disease associations based on maximum weighted matching inference model and motif-based analysis</article-title>
        <source>BMC Genomics</source>
        <year>2015</year>
        <volume>16</volume>
        <issue>5</issue>
        <fpage>S12</fpage>
        <?supplied-pmid 26040329?>
        <pub-id pub-id-type="pmid">26040329</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>MDHGI: matrix decomposition and heterogeneous graph inference for miRNA-disease association prediction</article-title>
        <source>PLoS Comput Biol</source>
        <year>2018</year>
        <volume>14</volume>
        <issue>8</issue>
        <fpage>e1006418</fpage>
        <?supplied-pmid 30142158?>
        <pub-id pub-id-type="pmid">30142158</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shannon</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Markiel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ozier</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Baliga</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Ramage</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Amin</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Schwikowski</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ideker</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>
        <source>Genome Res</source>
        <year>2003</year>
        <volume>13</volume>
        <issue>11</issue>
        <fpage>2498</fpage>
        <lpage>2504</lpage>
        <?supplied-pmid 403769?>
        <pub-id pub-id-type="pmid">14597658</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sayers</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brister</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Bolton</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Canese</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Comeau</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Funk</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ketter</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kimchi</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Database resources of the National Center for Biotechnology Information</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>48</volume>
        <issue>D1</issue>
        <fpage>D9</fpage>
        <lpage>D16</lpage>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dweep</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sticht</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pandey</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gretz</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>miRWalk - database: prediction of possible miRNA binding sites by “walking” the genes of three genomes</article-title>
        <source>J Biomed Inform</source>
        <year>2011</year>
        <volume>44</volume>
        <issue>5</issue>
        <fpage>839</fpage>
        <lpage>847</lpage>
        <?supplied-pmid 21605702?>
        <pub-id pub-id-type="pmid">21605702</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lewis</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Shih</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Jones-Rhoades</surname>
            <given-names>MW</given-names>
          </name>
          <name>
            <surname>Bartel</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Burge</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <article-title>Prediction of mammalian MicroRNA targets</article-title>
        <source>Cell</source>
        <year>2003</year>
        <volume>115</volume>
        <issue>7</issue>
        <fpage>787</fpage>
        <lpage>798</lpage>
        <?supplied-pmid 14697198?>
        <pub-id pub-id-type="pmid">14697198</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Juan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>miR2Disease: a manually curated database for microRNA deregulation in human disease</article-title>
        <source>Nucleic Acids Res</source>
        <year>2009</year>
        <volume>37</volume>
        <issue>suppl 1</issue>
        <fpage>D98</fpage>
        <lpage>D104</lpage>
        <?supplied-pmid 18927107?>
        <pub-id pub-id-type="pmid">18927107</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Geng</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>HMDD v2.0: a database for experimentally supported human microRNA and disease associations</article-title>
        <source>Nucleic Acids Res</source>
        <year>2014</year>
        <volume>42</volume>
        <issue>D1</issue>
        <fpage>D1070</fpage>
        <lpage>D1074</lpage>
        <?supplied-pmid 24194601?>
        <pub-id pub-id-type="pmid">24194601</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Enerly</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Steinfeld</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Kleivi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Leivonen</surname>
            <given-names>S-K</given-names>
          </name>
          <name>
            <surname>Aure</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Russnes</surname>
            <given-names>HG</given-names>
          </name>
          <name>
            <surname>Rønneberg</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Johnsen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Navon</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rødland</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>2</issue>
        <fpage>e16915</fpage>
        <?supplied-pmid 21364938?>
        <pub-id pub-id-type="pmid">21364938</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>mirPD: a pattern-based approach for identifying microRNAs from deep sequencing data</article-title>
        <source>Digit Signal Process</source>
        <year>2013</year>
        <volume>23</volume>
        <issue>6</issue>
        <fpage>1887</fpage>
        <lpage>1896</lpage>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Prediction of disease-related microRNAs through integrating attributes of microRNA nodes and multiple kinds of connecting edges</article-title>
        <source>Molecules</source>
        <year>2019</year>
        <volume>24</volume>
        <issue>17</issue>
        <fpage>3099</fpage>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Correlating bladder cancer risk genes with their targeting MicroRNAs using MMiRNA-tar</article-title>
        <source>Genomics Proteomics Bioinformatics</source>
        <year>2015</year>
        <volume>13</volume>
        <issue>3</issue>
        <fpage>177</fpage>
        <lpage>182</lpage>
        <?supplied-pmid 26169799?>
        <pub-id pub-id-type="pmid">26169799</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meder</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Backes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Haas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Leidinger</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Stähler</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Großmann</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vogel</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Frese</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Giannitsis</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Katus</surname>
            <given-names>HA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Influence of the confounding factors age and sex on MicroRNA profiles from peripheral blood</article-title>
        <source>Clin Chem</source>
        <year>2014</year>
        <volume>60</volume>
        <issue>9</issue>
        <fpage>1200</fpage>
        <lpage>1208</lpage>
        <?supplied-pmid 24987111?>
        <pub-id pub-id-type="pmid">24987111</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arora</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Qureshi</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>W-Y</given-names>
          </name>
        </person-group>
        <article-title>miR-506 regulates epithelial Mesenchymal transition in breast cancer cell lines</article-title>
        <source>PLoS One</source>
        <year>2013</year>
        <volume>8</volume>
        <issue>5</issue>
        <fpage>e64273</fpage>
        <?supplied-pmid 23717581?>
        <pub-id pub-id-type="pmid">23717581</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lv</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Lv</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>MiR-506 over-expression inhibits proliferation and metastasis of breast cancer cells</article-title>
        <source>Med Sci Monit</source>
        <year>2015</year>
        <volume>21</volume>
        <fpage>1687</fpage>
        <?supplied-pmid 26059632?>
        <pub-id pub-id-type="pmid">26059632</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>miR-506 regulates breast cancer cell metastasis by targeting IQGAP1</article-title>
        <source>Int J Oncol</source>
        <year>2015</year>
        <volume>47</volume>
        <issue>5</issue>
        <fpage>1963</fpage>
        <lpage>1970</lpage>
        <?supplied-pmid 26398880?>
        <pub-id pub-id-type="pmid">26398880</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ishihara</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tsuno</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ping</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ashizaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nakashima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Miura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Miura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamashita</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hasegawa</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Miura</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Hsa-miR-520d-5p promotes survival in human dermal fibroblasts exposed to a lethal dose of UV irradiation</article-title>
        <source>NPJ Aging Mech Dis</source>
        <year>2016</year>
        <volume>2</volume>
        <fpage>16029</fpage>
        <?supplied-pmid 28721278?>
        <pub-id pub-id-type="pmid">28721278</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>Z-l</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>H-j</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>F-Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>L-J</given-names>
          </name>
        </person-group>
        <article-title>Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>2</issue>
        <fpage>1477</fpage>
        <?supplied-pmid 26621835?>
        <pub-id pub-id-type="pmid">26621835</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Barrett</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wilhite</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Ledoux</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Evangelista</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>IF</given-names>
          </name>
          <name>
            <surname>Tomashevsky</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Phillippy</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Sherman</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Holko</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NCBI GEO: archive for functional genomics data sets—update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>41</volume>
        <issue>D1</issue>
        <fpage>D991</fpage>
        <lpage>D995</lpage>
        <?supplied-pmid 23193258?>
        <pub-id pub-id-type="pmid">23193258</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
